Also, is now on Telegram. While Oncology was once again the key growth driver, reasonable (but possibly transient) support came from ‘Respiratory + Immunology’, and New CVRM. Inspect before you invest. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors As on 30-06-2020, the company has a total of 25,000,000 shares outstanding. According to market rumours, AstraZeneca informally approached Gilead for a possible merger last month – if the deal goes ahead, it would be the biggest transaction in pharma industry to date. Hindustan Zinc 237.70 16.45. No action should be taken or omitted to be taken in reliance upon information on this webpage. Nifty 11,464.45 15.2. We accept no liability for the result of any action taken on the basis of the Information or for any loss from use of this webpage. AstraZeneca Pharma I Share Price Live - 4,015.55, AstraZeneca Pharma I Stock Price, Today - The Economic Times. Display price followed by previous trading day date. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. some of which is connected with London Stock Exchange plc("LSE")(the "LSE Information") and some of which is connected with (and has been made available on LSE's platform by the company that this particular webpage is dedicated to (the "company Information"), LSE attempts to ensure the LSE information is accurate, but has not and does not in any way review the Company Information and both sets of information are provided for information purpose only and are provided "AS IS" and on an "AS AVAILABLE" basis and may not be accurate or up to date. All rights reserved. All times stamps are reflecting IST (Indian Standard Time).By using this site, you agree to the Terms of Service and Privacy Policy. AstraZeneca Share price Reuters vaccine the serum institute of india the federal university of sao paulo pandemic astrazeneca (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. The potential vaccine’s much-lower price and multiple out-licensing deals, resulting in major capacities being secured, have been two critical miles ... AstraZeneca reported a healthy Q2 growth, outperforming closer peers like Novartis and Roche. NSE Gainer-Large Cap . Astrazen financial results, Astrazen shareholding, Astrazen annual reports, Astrazen pledge, Astrazen insider trading and compare with peer companies. Some trades qualify for deferred publication due to the type or size of the transaction. AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 801.26 Crore to Sales Value (96.32 % of Total Sales), Sale of services which contributed Rs 30.51 Crore to Sales Value (3.66 % of Total Sales), Scrap which contributed Rs .04 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2020. When the traded price is any other currency then the Trade Value is displayed in that currency. © 2020 London Stock Exchange. For instruments denominated in GBX, the Trade Value is in GBP when the traded currency is GBX or GBP. View Details On AstraZeneca Pharma India Ltd, Better performer than its peers on this ratio, Average performer than its peers on this ratio, Underperformer than its peers on this ratio, India's 1st Online Instant Personal Loan Marketplace, Buy AstraZeneca Pharma, target price Rs 3,300: Jayesh Bhanushali, AstraZeneca Pharma India Ltd. News & Updates, Market Movers: RIL rises; Astrazeneca tumbles; 281 stocks hit lower circuits, Stock market update: BSE SmallCap index falls over 1%; Kirloskar tanks 7%, Stock market news: AstraZeneca Pharma shares tank nearly 6%, Sebi censures Astrazeneca Pharma's promoter, Elliot Group, AstraZeneca gets extension for Meronem withdrawal till August 31, AstraZeneca gets marketing nod for asthma drug Symbicort, AstraZeneca Pharma India Q4 net loss at Rs 2.87 crore, Mapping the market: NPAs haunted bank stocks; smallcaps led broadbased selling, Twelve stocks in focus on Wednesday, 10 August 2016, Fifteen stocks in focus in Monday morning trade, AstraZeneca Q3 net profit at Rs 8.67 crore, Fed cheer!